Kinnate Biopharma
Striding toward
Kinnate Biopharma is driven by the urgency of cancer patients who need more effective therapies. By using next-generation genomic, molecular, and medicinal chemistry tools, they have built a best-in-class and first-in-class portfolio of kinase inhibitors targeting hard-to-treat, genetically defined cancers.
A few years before their successful acquisition in 2024, we were tasked with helping them communicate that vision to the investment and science worlds to attract critical capital and talent.
Services
An acquisition
Visualizing the target sources of their oncology work helped them to dramatize the powerful work of their science and technology.Â
Part of the goal was to create a visual language that reflected their essence as ‘bio-nauts of our body’s inner space’. We created a darker theme and let the imagery of tumors and chromosomes emanate from within.
Kinnate6_VideoPlaceholder_@2x
We created models of damaged chromosomes and tumors that we could render as videos or still assets to break down their science for different audiences.
Kinnate2_@2x
The reverse arrow in the identity represents Kinnate’s approach of working backwards from genetic markers to find the source of the cancers.
kinnate website
The website told the story of their pipeline development and the sorts of patients their treatments could help.
Frame 304
We shot their team all over the country during Covid lockdown which proved to be a logistical puzzle.
KinnateStyleguideTemplate
And created a guide for the team to come back to.
From the clients
Share this: